2023
DOI: 10.1016/j.xinn.2022.100364
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic network biomarker factors orchestrate cell-fate determination at tipping points during hESC differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 33 publications
(54 reference statements)
0
6
0
Order By: Relevance
“…A biological process can be seen as a dynamic process with gene expressions as variables [ 34 , 35 ]. Even in a single cell, the gene expression is always changing with time and cell state, which results in the difficulty to quantify cell heterogeneity and CCC.…”
Section: Discussionmentioning
confidence: 99%
“…A biological process can be seen as a dynamic process with gene expressions as variables [ 34 , 35 ]. Even in a single cell, the gene expression is always changing with time and cell state, which results in the difficulty to quantify cell heterogeneity and CCC.…”
Section: Discussionmentioning
confidence: 99%
“…Many diseases result from systematic failures [ 14 , 15 ] and the aging of multiple organs rather than one [ 3 ]. The key switches and master regulators are hubs for stem cell medicine [ 16 ], with early warning signals of the diseases’ tipping points detecting imminent critical transitions [ 17 ].…”
Section: Stem Cell Medicine: Updated Research Highlightsmentioning
confidence: 99%
“…Vitamin D receptor (Daf-12) as an evolutionarily conserved upstream master regulator for both Mi-2/LET-418 and mTOR/LET-363, acts as a “capacitor” like Hsp90 (chaperone-mediated autophagy) [ 25 ]. Detecting degeneration during the early phases of age-related diseases could potentially stop or delay them [ 17 ], including cancer. Potentially rejuvenating aged stem cells [ 26 ] through combining the use of chemical molecules, such as rapalogs, metformin, senolytics, nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), histone deacetylase (HDAC) inhibitors and exogenous stem cells [ 10 ] or stem cell derivatives [ 8 ] and the like [ 9 ], could maximize the positive effects of each individual component while minimizing the side effects of drugs with the potential of “hit-and-run” style.…”
Section: Key Issues Opportunities and Advancesmentioning
confidence: 99%
“…From a scRNA-seq dataset of mouse hematopoietic stem cells, a DNB analysis was able to distinguish three different types of transcriptomic variations that corresponded to different cell fates [ 31 ]. Strikingly, Li et al recently reported a module-based DNB (M-DNB) model used for cell fate determination during the differentiation process in human embryonic stem cells (hESCs) [ 32 ]. This M-DNB model, which transforms gene expression information into gene modules/networks based on a protein–protein interaction network, is optimized for scRNA-seq datasets, which often contain higher levels of transcript amplification noise and drop-out events.…”
Section: Dynamical Network Biomarkers Theorymentioning
confidence: 99%
“…This M-DNB model, which transforms gene expression information into gene modules/networks based on a protein–protein interaction network, is optimized for scRNA-seq datasets, which often contain higher levels of transcript amplification noise and drop-out events. Using this model, they identified the key regulators of hESC differentiation as the M-DNB factors, including FOS , HSF1 , MYCN , TP53 , and MYC , with FOS being activated in the first tipping point and MYC in the second [ 32 ]. There are common biological features between ESCs and cancer stem cells (CSCs) [ 38 ].…”
Section: Dynamical Network Biomarkers Theorymentioning
confidence: 99%